Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.35% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.62% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Coherus Oncology
CHRS
$128M
| $495K | ﹤0.01% |
353,922
+18,613
| +6% | +$30.4K |
2019 Q1
29 quarters
|
|
3177
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.27B
| $493K | ﹤0.01% |
2,543
| – | – |
2026 Q1
1 quarter
|
|
3178
Lightpath Technologies
LPTH
$567M
| $491K | ﹤0.01% |
+30,047
| New | +$419K |
2026 Q2
0 quarters
|
|
3179
Bankwell Financial Group
BWFG
$568M
| $491K | ﹤0.01% |
8,362
+2,042
| +32% | +$108K |
2025 Q3
3 quarters
|
|
3180
Federated Hermes Premier Municipal Income Fund
FMN
$82.1M
| $491K | ﹤0.01% |
+42,722
| New | +$479K |
2026 Q2
0 quarters
|
|
3181
Nano Nuclear Energy
NNE
$626M
| $490K | ﹤0.01% |
23,168
-10,975
| -32% | -$270K |
2025 Q1
5 quarters
|
|
3182
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$8.02B
| $489K | ﹤0.01% |
30,776
-858
| -3% | -$15.1K |
2022 Q1
17 quarters
|
|
3183
Primis Financial Corp
FRST
$365M
| $488K | ﹤0.01% |
29,828
+7,781
| +35% | +$114K |
2024 Q1
9 quarters
|
|
3184
Daily Journal
DJCO
$867M
| $488K | ﹤0.01% |
811
-228
| -22% | -$119K |
2024 Q2
8 quarters
|
|
3185
Jakks Pacific
JAKK
$362M
| $487K | ﹤0.01% |
20,913
-7,107
| -25% | -$157K |
2024 Q4
6 quarters
|
|
3186
Viemed Healthcare
VMD
$368M
| $486K | ﹤0.01% |
42,598
+15,362
| +56% | +$152K |
2023 Q2
12 quarters
|
|
3187
Lands' End
LE
$281M
| $485K | ﹤0.01% |
46,280
+1,676
| +4% | +$19.3K |
2014 Q2
48 quarters
|
|
3188
Ares Commercial Real Estate
ACRE
$186M
| $485K | ﹤0.01% |
107,723
+2,380
| +2% | +$11.7K |
2013 Q4
50 quarters
|
|
3189
Oportun Financial
OPRT
$455M
| $483K | ﹤0.01% |
84,644
-8,970
| -10% | -$48K |
2020 Q1
25 quarters
|
|
3190
Zenas BioPharma
ZBIO
$1.85B
| $481K | ﹤0.01% |
18,954
-94,525
| -83% | -$1.88M |
2025 Q3
3 quarters
|
|
3191
Tonix Pharmaceuticals
TNXP
$87.5M
| $481K | ﹤0.01% |
37,691
+22,426
| +147% | +$289K |
2026 Q1
1 quarter
|
|
3192
Aktis Oncology
AKTS
$886M
| $480K | ﹤0.01% |
14,908
+2,795
| +23% | +$57.4K |
2026 Q1
1 quarter
|
|
3193
Strive Inc
ASST
$2.83B
| $480K | ﹤0.01% |
44,018
+16,525
| +60% | +$245K |
2025 Q4
2 quarters
|
|
3194
Aimco
AIV
$228M
| $480K | ﹤0.01% |
161,603
+8,738
| +6% | +$33.5K |
2013 Q2
52 quarters
|
|
3195
iShares MSCI Poland ETF
EPOL
$1.03B
| $480K | ﹤0.01% |
12,430
-532
| -4% | -$20.9K |
2025 Q1
5 quarters
|
|
3196
Verastem
VSTM
$1.18B
| $478K | ﹤0.01% |
125,077
+21,028
| +20% | +$102K |
2024 Q2
8 quarters
|
|
3197
Karat Packaging
KRT
$1.08B
| $478K | ﹤0.01% |
14,274
+6,850
| +92% | +$197K |
2026 Q1
1 quarter
|
|
3198
MacroGenics
MGNX
$153M
| $476K | ﹤0.01% |
102,985
-9,388
| -8% | -$35.5K |
2014 Q4
46 quarters
|
|
3199
Virtus Convertible & Income Fund II
NCZ
$266M
| $476K | ﹤0.01% |
29,911
-3,696
| -11% | -$56.4K |
2024 Q3
7 quarters
|
|
3200
Mistras Group
MG
$643M
| $473K | ﹤0.01% |
27,084
-3,220
| -11% | -$57.3K |
2023 Q3
11 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.